Influence of botulinum toxin on myogenous facial pain

被引:0
|
作者
Seedorf, H
Leuwer, R
Bussopulos, A
Fenske, C
Jüde, HD
机构
[1] Univ Hamburg, Klinikum Eppendorf, Klin & Poliklin Zahn Mund & Kieferheilkunde, Abt Zahnarztliche Prothet, D-20246 Hamburg, Germany
[2] Univ Hamburg, Klinikum Eppendorf, Klin & Poliklin Hals Nasen & Ohrenheilkunde, Hamburg, Germany
[3] Univ Hamburg, Klinikum Eppendorf, Neurol Klin & Poliklin, Hamburg, Germany
来源
SCHMERZ | 2005年 / 19卷 / 01期
关键词
facial pain; orofacial pain; masticatory muscles; botulinum toxin; therapy;
D O I
10.1007/s00482-003-0296-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. Can chronic pain of the masticatory muscles be positively affected by low dose injection of botulinum toxin (BTX-A)? Methods. Twenty patients suffering chronic myofacial pain were questioned and examined after injection of 25-50 U Dysport((R)) into the affected muscles over a period of 8 weeks. Results. Four weeks after injection of BTX-A patients reported a significant reduction of pain (p < 0.001, paired t-test. Power of performed test with alpha 0,050:1.000). Then the pain remained constant over the next 4 weeks. Concurrently a significant increase of mandubular range of movement was observed (p < 0,05, Wilcoxon signed rank test). Conclusions. Even though lacking placebo control the findings suggest that patients suffering chronic myofacial pain may benefit from injection of low dose BTX-A into the affected muscles.
引用
收藏
页码:18 / +
页数:7
相关论文
共 50 条
  • [41] Persistent Facial Blanching after Botulinum Toxin Injection
    Mitri, Fouad
    Kaelber, Katharina Anna
    Enk, Alexander H.
    Toberer, Ferdinand
    CASE REPORTS IN DERMATOLOGY, 2022, 14 (02): : 253 - 256
  • [42] Botulinum toxin for the treatment of bruxism
    Tinastepe, Neslihan
    Kucuk, Burcu Bal
    Oral, Koray
    CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2015, 33 (04): : 292 - 299
  • [43] Botulinum Toxin for Neurogenic and Non-neurogenic Bladder Pain
    Ly Hoang Roberts
    Jason P. Gilleran
    Current Bladder Dysfunction Reports, 2022, 17 : 38 - 47
  • [44] Botulinum toxin and facial palsy. Our experience
    Navarrete Alvaro, Maria Luisa
    Junyent, Josefina
    Torrent, Luisa
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2010, 61 (04): : 277 - 281
  • [45] Botulinum toxin treatment for facial palsy: A systematic review
    Cooper, Lilli
    Lui, Michael
    Nduka, Charles
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2017, 70 (06) : 833 - 841
  • [46] Treatment of facial myokymia in multiple sclerosis with botulinum toxin
    Habek, Mario
    Adamec, Ivan
    Gabelic, Tereza
    Brinar, Vesna V.
    ACTA NEUROLOGICA BELGICA, 2012, 112 (04) : 423 - 424
  • [47] Facial Hemiplegia Treated with Botulinum Toxin: A Case Report
    Ajuz, Demetrio
    Oliveira, Mauro D. D.
    Fernandes, Juliana Campos Hasse
    de Oliveira Fernandes, Gustavo Vicentis
    DISEASES, 2022, 10 (04)
  • [48] Botulinum toxin for ocular complications after facial palsy
    Suarez, E. Torres
    OPHTHALMOLOGE, 2012, 109 (03): : 292 - 296
  • [49] The use of botulinum toxin type A in cosmetic facial procedures
    Jaspers, G. W. C.
    Pijpe, J.
    Jansma, J.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2011, 40 (02) : 127 - 133
  • [50] Botulinum toxin effects on pain in cervical dystonia
    Osawa, M
    Iwata, M
    CEPHALALGIA, 2005, 25 (10) : 992 - 992